Live
- Two Russian oil tankers with 29 on board damaged due to bad weather
- Telangana's Traditions Will Be Protected, Village by Village : BRS Leader MLC K. Kavitha
- Uganda to relocate 5,000 households from landslide-prone areas in eastern region
- Harish Rao Criticizes CM Revanth Reddy: "His Time is Over"
- Vijay Sethupathi Hails 'Vidudala-2' as a Theatrical Game-Changer
- Sahaj Yog: A Path to Inner Transformation and Harmony City takes giant strides
- Allu Arjun meets his uncle Nagababu at his residence
- J&K L-G felicitates Langar organisations & NGOs for contribution during Amarnath Yatra
- Hit by Covid, MP's Rakesh Mishra sees revival of his fortunes, courtesy PM SVANidhi scheme
- Trailblazing Yakshagana Artiste Leelavathi Baipaditthaya No More
India to miss July vaccination target as Bharat Biotech lags
India to miss July vaccination target as Bharat Biotech lags (File Photo)
India will miss a target to administer over a half billion Covid-19 vaccine doses by the end of the month as Bharat Biotech - maker of country's only approved homegrown shot - struggles to boost output, an analysis of government data showed on Monday.
New Delhi: India will miss a target to administer over a half billion Covid-19 vaccine doses by the end of the month as Bharat Biotech - maker of country's only approved homegrown shot - struggles to boost output, an analysis of government data showed on Monday. India has undertaken one of the world's largest vaccination drives and has so far distributed some 430 million doses - more than any country except China, but less than many countries relative to its population.
The government said in May it would make 516 million shots available by the end of July. It wants to inoculate all its estimated 944 million adults by December.
To meet the July-end target, however, authorities will have to more than triple average daily vaccinations to 14 million doses. But that will not be possible, based on the latest supply projections for Bharat Biotech's Covaxin vaccine.
The government had been counting on deliveries of 60 million to 70 million Covaxin doses monthly from July or August.
But Bharat Biotech will only supply 25 million doses this month and 35 million in August as a new production line in the southern city of Bengaluru takes time to come online, Union Health Minister Mansukh Mandaviya told parliament last week. He said the supply shortfall "would not affect our immunisation programme".
